Could cause temporary or reversible harm; serious harm is unlikely.
Failed Dissolution Specifications: Out-of-specification results for dissolution (above specification)
| Brand name | EXTENDED PHENYTOIN SODIUM |
| Generic name | PHENYTOIN SODIUM |
| Active ingredient(s) | PHENYTOIN SODIUM |
| Distributed by / for | Amneal Pharmaceuticals LLC., Bridgewater, NJ 08807 |
| NDC | 65162-212-10 |
| Full product label | Extended Phenytoin Sodium Capsules, USP, 100 mg, Rx Only, 100 capsules per bottle, Distributed by: Amneal Pharmaceuticals LLC., Bridgewater, NJ 08807, NDC 65162-212-10. |
| Recalling firm | Amneal Pharmaceuticals of New York, LLC |
| Distribution | LA, PA and OH. |
| Quantity | 9,056 bottles |
| Recall initiated | 2023-05-30 |
| Report date | 2023-06-21 |
| Recall completed | 2025-06-10 |
| Recall number | D-0876-2023 |
| Classification | Class II |
| FDA status | Terminated |
| Origin on file | Brookhaven NY United States |
Source: U.S. FDA enforcement database (openFDA). Look this up on the official FDA recalls site ↗